Delivery Order HHSN272201300003I-HHSN27200003
Ended Awarded Last action
- Contract number
- HHSN27200003
- Awardee
-
Bioqual, Inc. UEI CK9LGQ7EBNN8
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,077,152
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2012138 Solicitation number
- Contract value 76% obligated
- $1,411,306.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$24,907 | |
| Change Order | $359,062 | |
| Original award | $1,077,152 |
About this award
Bioqual, Inc. was awarded a delivery order valued at $1.41 million by the National Institute of Allergy and Infectious Diseases (NIAID) on May 1, 2013, for Simian Vaccine Evaluation Units. This cost-plus-fixed-fee contract, which concluded on April 30, 2015, was performed in Potomac, Maryland, and represents work under the broader Simian Vaccine Evaluation Units 2013-2020 indefinite delivery vehicle. No set-aside designation was applied to this award, allowing Bioqual to compete in the open federal procurement process. NIAID, a component of the National Institutes of Health, funds this work as part of its mission to conduct and support research on infectious diseases and vaccine development.
Bioqual, a biomedical research services company based in Rockville, Maryland, specializes in providing advanced scientific research support to federal agencies, with particular expertise in preclinical animal studies and laboratory analysis. The company's substantial track record with NIAID includes multiple contract vehicles focused on developing and evaluating animal models for infectious disease countermeasures, including non-human primate models critical to vaccine evaluation efforts. This delivery order aligns with Bioqual's core competencies in supporting sophisticated vaccine development research through specialized animal model work and experimental study services.
Quick answers
Who was awarded contract HHSN27200003?
HHSN27200003 was awarded to Bioqual, Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on May 1, 2013.
How much is contract HHSN27200003 worth?
The government has obligated $1,077,152 on HHSN27200003. Its current value, with exercised options, is $1,411,307.
Is contract HHSN27200003 an order under another contract?
Yes. HHSN27200003 is a delivery order under HHSN272201300003I, an indefinite delivery contract, on Simian Vaccine Evaluation Units 2013-2020.
Was contract HHSN27200003 competed?
The extent of competition for HHSN27200003 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award